Evidence map›Paper›PMID 28611202›Full record

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017

Role of Platelet-Derived Tgfβ1 in the Progression of Ovarian Cancer.

Qianghua Hu, Takeshi Hisamatsu, Monika Haemmerle, Min Soon Cho, Sunila Pradeep, Rajesha Rupaimoole, Cristian Rodriguez-Aguayo, Gabriel Lopez-Berestein, Stephen T C Wong, Anil K Sood and 1 more

Open access · greenAbstract read
In one paragraph

Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 1 synthesis or guideline pooled it, 103 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Liquid biopsy in bladder cancer: towards precision oncology.Journal of translational medicine · 2026
    Review
  4. Review
  5. Platelets as regulators of cancer immunity: mechanisms and therapeutic perspectives.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Engineering platelets as cancer therapeutics.Nature reviews. Clinical oncology · 2026
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Qianghua HuDepartment of Benign Hematology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Takeshi HisamatsuGynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Monika HaemmerleGynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Min Soon ChoDepartment of Benign Hematology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Sunila PradeepGynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Rajesha RupaimooleGynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Cristian Rodriguez-AguayoExperimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Gabriel Lopez-BeresteinExperimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Stephen T C WongDepartment of Systems Medicine and Bioengineering, Houston Methodist Research Institute, Weill Cornell Medicine, Houston, Texas.
Anil K SoodGynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. vakharghan@mdanderson.org asood@mdanderson.org.
Vahid Afshar-KharghanDepartment of Benign Hematology, The University of Texas MD Anderson Cancer Center, Houston, Texas. vakharghan@mdanderson.org asood@mdanderson.org.
The University of Texas MD Anderson Cancer Center · USHouston Methodist · US

Funding

Platelets promote growth of ovarian cancerR01CA177909 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI AFSHAR-KHARGHAN, VAHID, SOOD, ANIL K · 2013 to 2023
$4.1M
NCI NIH HHS R01 CA177909
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gene ExpressionAnimalsBlood PlateletsCell Line, TumorCell ProliferationDisease Models, AnimalDisease ProgressionFemaleHeterograftsHumansImmunohistochemistryMiceMice, TransgenicNeovascularization, PathologicOvarian NeoplasmsRNA, Small InterferingRNA, Small InterferingTransforming Growth Factor beta1

Identifiers

PMID28611202
PMCPMC5600833
OpenAlexW2626366907

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.